Guru Ownership Trend
Guru Analysis for Janux Therapeutics, Inc. (JANX)
Janux Therapeutics, Inc. (JANX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $35.34 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $14.5 M net inflow during the quarter.
Recent activity highlights Cliff Asness who opened a new position. Conversely, Paul Tudor Jones reduced exposure by 5.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Janux Therapeutics, Inc. (JANX)
Major holders include Steven Cohen ($30.63 M), Cliff Asness ($1.66 M), Paul Tudor Jones ($431,155). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.13 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $14.5 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited JANX. The total reported sell value was $24,867.83.
Yes, 1 managers opened new positions in JANX, and 1 increased their existing holdings. The total reported buy value was $14.53 M.